Generic placeholder image

Recent Patents on Drug Delivery & Formulation

Editor-in-Chief

ISSN (Print): 1872-2113
ISSN (Online): 2212-4039

Chronopharmaceutics: A Promising Drug Delivery Finding of the Last Two Decades

Author(s): Javed Ali, Nitin Saigal, Mohd. J. Qureshi, Sanjula Baboota and Alka Ahuja

Volume 4, Issue 2, 2010

Page: [129 - 144] Pages: 16

DOI: 10.2174/187221110791184962

Price: $65

Abstract

Pulsatile drug delivery system capable of releasing the drug after a predetermined lag period in pulsed or controlled release manner recently has drawn the attention of both academic and industrial research. Depending on the effective therapeutic application of the drug, a variety of design strategies have been formulated in the pursuit of pulsatile release. Circadian (24 hr cycle) dependency of various physiological and pathological functions is well established, thus, it becomes imperative to develop a drug delivery system to achieve release of drug at specific site and time. Such systems are advantageous for drugs which have an extensive first pass metabolism, biological tolerance, needs targeting of locally absorbed /active drug to a specific site in intestine and are useful for the therapy for chronopharmacological needs. This manuscript portrays the important patents related to chronomodulated release system such as system with eroding, rupturing or soluble barrier coatings. In addition, recently developed chronotherapeutic dosage forms including tablets, capsules, pellets, beads implants, osmotic pump, liposome, thermoresponsive, inflammation stimuli sensitive, electrical stimuli sensitive, ultrasound stimuli responsive, magnetic stimuli responsive etc. are also conferred.

Keywords: Chronomodulation, pulsatile systems, circadian rhythm, lag time, swellable system, rupturable system, erodible system, stimuli sensitive system


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy